![Bill Arthur](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Bill Arthur worked as the Head of Research and Vice President at Neoleukin Therapeutics, Inc. from 2021 to 2023.
Prior to this, he earned a doctorate degree from The University of North Carolina at Chapel Hill and an undergraduate degree from Western Washington University.
Former positions of Bill Arthur
| Companies | Position | End |
|---|---|---|
| NEUROGENE INC. | Chief Tech/Sci/R&D Officer | 01/03/2023 |
Training of Bill Arthur
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
9
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Washington University
 Western Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Develops de novo – therapeutic proteins to treat serious immunological disorders, including cancer and autoimmunity | Health Technology |
- Stock Market
- Insiders
- Bill Arthur
